LPL Financial
GRTX

LPL Financial’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

LPL Financial’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,102
Closed -$2.53K – 5178
2024
Q1 		$2.53K Buy
18,102
+269
+2% +$53 ﹤0.01% 4905
2023
Q4 		$2.59K Sell
17,833
-18,200
-51% -$2.83K ﹤0.01% 4784
2023
Q3 		$6.31K Sell
36,033
-1,202
-3% -$1.49K ﹤0.01% 4666
2023
Q2 		$116K Buy
37,235
+5,000
+16% +$14.9K ﹤0.01% 4298
2023
Q1 		$82.5K Buy
+32,235
New +$66.5K ﹤0.01% 4243

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

LPL Financial's GRTX Position: Q2 2024 in Review

LPL Financial sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 18,102 shares — an estimated $2.53K sold.

LPL Financial first reported a position in GRTX in Q1 2023 and held it in 5 quarters. The position peaked at $116K in Q2 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • LPL Financial reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • LPL Financial sold 18,102 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $2.53K.
  • LPL Financial first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • LPL Financial's Galera Therapeutics, Inc. Common Stock position peaked at $116K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on LPL Financial's 13F filing for Q2 2024, filed 7 Aug 2024.